The continuing debate: Conservative or interventional therapy for unstable coronary artery disease

American Journal of Cardiology

Volumn 80, Issue 5 A, 1997, Pages

  Hillis, W Stewart ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DALTEPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0030812832     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00491-8     Document Type: Conference Paper

References (31)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RD, Smith EE Jr, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 28:1996;1328-1428.
2. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary lesions. Experimental evidence and potential clinical implications. Circulation. 80:1989;198-205.
3. Keen WD, Savage MP, Fischman DL, Zalewski A, Walinsky P, Nardone D, Goldberg S. Comparison of coronary angiographic findings during the first 6 hours of non-Q-wave and Q-wave myocardial infarction. Am J Cardiol. 74:1994;324-328.
4. Braunwald E. Unstable angina: a classification. Circulation. 80:1989;410-414.
5. Braunwald E, Jones RH, Mark DB. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation. 90:1994;613-622.
6. Brown CA, Hutter AM Jr, DeSanctis RW, Gold HK, Leinbach RC, Roberts-Niles A, Austen WG, Buckley MJ. Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: results of in-hospital and chronic mortality and morbidity. Am Heart J. 102:1981;959-964.
7. Théroux P, Walters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 327:1992;141-145.
8. Hirsh J. Heparin. N Engl J Med. 324:1991;1565-1574.
9. Gurfinkel EP, Manos EJ, Mejail RI, Cerda MA, Duronto EA, Garcia CN, Daroca AM, Mautrier B. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischaemia. J Am Coll Cardiol. 26:1995;313-318.
10. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
11. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G. Turpie AGG, van der Meer J, Olaisson E, Undeland S, Ludwig K, for the FRIC Investigators. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Circulation. 96:1997;61-68.
12. Cohen M, Demers C, Gurfinkel EP, Turpie AGG, Fromell GJ, Goodman S, Langer A, Califf, RM, Fox KAA, Premmereur J, Bigonzi F, for the ESSENCE Study Group. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997; (in press).
13. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation. 90:1994;1631-1637.
14. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 335:1996;775-782.
15. Simoons ML, de Boer MJ, van den Brand MJBM. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group. Circulation. 89:1994;596-603.
16. White H. PRISM Study. Reported at the 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, USA, 16-19, March, 1997.
17. Théroux P. PRISM PLUS Study. Reported at the 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, USA, 16-19, March, 1997.
18. Théroux P, Kouz S, Roy L, Knudtson ML, Diodati JG, Marquis JF, Nasmith J, Fung AY, Boudreault JR, Delage F, Dupuis R, Kells C, Bokslag M, Steiner B, Rapold HJ. Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study. Circulation. 94:1996;899-905.
19. Davis K, Ward Kennedy J, Kemp HG Jr, Judkins MP, Grosselin AJ, Killip T. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation. 59:1979;1105-1112.
20. Stammen F, De Scheerder I, Glazier JJ, Van Lierde J, Vrolix M, Willems JL, De Geest H, Piessens J. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris. Am J Cardiol. 69:1992;1533-1537.
21. Gotoh K, Minamino T, Katoh O, Hamano Y, Fukui S, Hori M, Kusuoka H, Mishima M, Inoue M, Kamada T. The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation. 77:1988;526-534.
22. Sugrue DD, Holmes DR, Smith HC, Reeder GS, Lane GE, Vlietstra RE, Bresnahan JF, Hammes LN, Piehler JM. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. Br Heart J. 56:1986;62-66.
23. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
24. Halon DA, Merdler A, Shefer A, Flugelman MY, Lewis BS. Identifying patients at high risk of restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. Am J Cardiol. 64:1989;289-293.
25. Williams DO, Braunwald E, Thompson B, Sharat BL, Buller CE, Knatterud GL. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI-IIIB Trial. Circulation. 94:1996;2749-2755.
26. Unstable angina pectoris. Am J Cardiol. 42:1978;839-848.
27. Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J Med. 316:1987;977-984.
28. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial (Thrombolysis in Myocardial Ischemia). Circulation. 89:1994;1545-1556.
29. Boden WE. VANQWISH Study. Reported at the 46th Annual Scientific Sessions of the American College of Cardiology, Anaheim, CA, USA, 16-19, March, 1997.
30. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. ii:1988;349-360.
31. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. i:1986;397-402.